Open AccessA myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study
Author(s) -
Uday Popat,
Börje S. Andersson,
Roland Bassett,
Jitesh D. Kawedia,
Ben C. Valdez,
Amin M. Alousi,
Gheath Alatrash,
Qaiser Bashir,
Chitra Hosing,
Jin S. Im,
Partow Kebriaei,
David Marín,
Yago Nieto,
Betül Oran,
Amanda Olson,
Muzaffar H. Qazilbash,
Samer A. Srour,
Elizabeth J. Shpall,
Richard E. Champlin,
Rohtesh S. Mehta
Publication year - 2022
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2022.280778
Subject(s) - busulfan , cyclophosphamide , medicine , transplantation , human leukocyte antigen , conditioning regimen , oncology , immunology , chemotherapy , antigen